What is Pfizer's debt securities, amortized cost basis?

Pfizer (PFE) reported debt securities, amortized cost basis of $9.53B in Q1 2026.

How has Pfizer's debt securities, amortized cost basis changed year-over-year?

Pfizer's debt securities, amortized cost basis decreased by 36.2% year-over-year, from $14.94B to $9.53B.

What is the long-term trend for Pfizer's debt securities, amortized cost basis?

Over 5 years (2020 to 2025), Pfizer's debt securities, amortized cost basis has grown at a -0.1% compound annual growth rate (CAGR), from $9.99B to $9.94B.

Pfizer PFE Debt Securities, Amortized Cost Basis

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept pfe:DebtSecuritiesAmortizedCostBasis.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's debt securities, amortized cost basis.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's debt securities, amortized cost basis?: Pfizer (PFE) reported debt securities, amortized cost basis of $9.53B in Q1 2026.
How has Pfizer's debt securities, amortized cost basis changed year-over-year?: Pfizer's debt securities, amortized cost basis decreased by 36.2% year-over-year, from $14.94B to $9.53B.
What is the long-term trend for Pfizer's debt securities, amortized cost basis?: Over 5 years (2020 to 2025), Pfizer's debt securities, amortized cost basis has grown at a -0.1% compound annual growth rate (CAGR), from $9.99B to $9.94B.